Literature DB >> 2692533

UTP/CTP ratio, an important regulatory parameter for ATCase expression.

G A O'Donovan1, S Herlick, D E Beck, P K Dutta.   

Abstract

Intracellular nucleotides of Salmonella typhimurium were separated and quantified by high performance liquid chromatography (HPLC). Wild type and specially constructed strains of S. typhimurium, in which uridine and cytidine nucleotides could be manipulated independently, were used in this study. By varying growth conditions it was possible to create different concentrations of uridine and cytidine nucleotides in the cell. The specific activity of ATCase was determined for each condition. Generally, a direct correlation was found: at high nucleotide (UTP) concentrations, maximal repression of ATCase was usually seen; at low nucleotide (UTP) concentrations ATCase was derepressed. However, it was the ratio of the concentrations of UTP-to-CTP rather than either the concentration of UTP or CTP alone that best determined the extent of ATCase expression. This applied to all conditions in the present work as well as to all conditions in work hitherto reported by others. The ratio of UTP/CTP is proposed as a key regulatory parameter for pyr enzyme expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692533     DOI: 10.1007/bf00277535

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  32 in total

1.  Uridine-cytidine kinase from Escherichia coli.

Authors:  P Valentin-Hansen
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

2.  pyrR identical to pyrH in Salmonella typhimurium: control of expression of the pyr genes.

Authors:  J Justesen; J Neuhard
Journal:  J Bacteriol       Date:  1975-09       Impact factor: 3.490

3.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

4.  Mutants of Salmonella typhimurium requiring cytidine for growth.

Authors:  J Neuhard; J Ingraham
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

5.  Negative cooperativity in regulatory enzymes.

Authors:  A Levitzki; D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

6.  Pyrimidine biosynthetic enzymes of Salmonella typhimurium, repressed specifically by growth in the presence of cytidine.

Authors:  R A Kelln; J J Kinahan; K F Foltermann; G A O'Donovan
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

7.  Apparent involvement of purines in the control of expression of Salmonella typhimurium pyr genes: analysis of a leaky guaB mutant resistant to pyrimidine analogs.

Authors:  K F Jensen
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

8.  Synthesis of aspartate transcarbamoylase in Escherichia coli: transcriptional regulation of the pyrB-pyrI operon.

Authors:  M Navre; H K Schachman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Pyrimidine nucleotide metabolism and pathways of thymidine triphosphate biosynthesis in Salmonella typhimurium.

Authors:  J Neuhard
Journal:  J Bacteriol       Date:  1968-11       Impact factor: 3.490

10.  RNA polymerase involvement in the regulation of expression of Salmonella typhimurium pyr genes. Isolation and characterization of a fluorouracil-resistant mutant with high, constitutive expression of the pyrB and pyrE genes due to a mutation in rpoBC.

Authors:  K F Jensen; J Neuhard; L Schack
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  2 in total

1.  Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.

Authors:  K Tamura; J Woo; M T Bakri; A W Thomson
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

2.  The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production.

Authors:  J Woo; B Lemster; K Tamura; T E Starzl; A W Thomson
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.